NovaBridge Biosciences (NBP) Invested Capital (2017 - 2025)
NovaBridge Biosciences (NBP) has 9 years of Invested Capital data on record, last reported at $230.9 million in Q4 2025.
- On a quarterly basis, Invested Capital rose 14.8% to $230.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $230.9 million, a 14.8% increase, with the full-year FY2025 number at $230.9 million, up 14.8% from a year prior.
- Invested Capital reached $230.9 million in Q4 2025 per NBP's latest filing, down from $258.9 million in the prior quarter.
- Over the last five years, Invested Capital for NBP hit a ceiling of $845.6 million in Q2 2021 and a floor of $196.7 million in Q2 2025.
- A 5-year average of $362.8 million and a median of $242.8 million in 2023 define the central range for Invested Capital.
- Peak YoY movement for Invested Capital: tumbled 42.26% in 2022, then rose 18.83% in 2025.
- Tracing NBP's Invested Capital over 5 years: stood at $713.2 million in 2021, then crashed by 42.26% to $411.8 million in 2022, then crashed by 41.04% to $242.8 million in 2023, then decreased by 17.15% to $201.2 million in 2024, then increased by 14.8% to $230.9 million in 2025.
- Business Quant data shows Invested Capital for NBP at $230.9 million in Q4 2025, $258.9 million in Q3 2025, and $196.7 million in Q2 2025.